September 2009 Supplement Research Papers

• September 9

  • Effects of date ( Phoenix dactylifera L., Medjool or Hallawi Variety) consumption by healthy subjects on serum glucose and lipid levels and on serum oxidative status: a pilot study.

    • 2009-09-09
    • Clinical Trial · n = 10
    • Journal of Agricultural and Food Chemistry 57(17)
    • • Wasseem Rock
      • M. Rosenblat
      • H. Borochov-Neori
      • N. Volkova
      • Sylvie Judeinstein
      • M. Elias
      • M. Aviram

    • PubMed: 19681613
    • DOI: 10.1021/jf901559a

    4 Insights on

    • Reduced Triglyceride Levels
    • Reduced Oxidative Damage in Serum
    • Reduced Lipid Peroxidation
    • Increased Paraoxonase 1 Enzyme Activity

    • High evidence
    • Highly Cited
• September 14

  • Consumption of a fermented dairy product containing the probiotic Lactobacillus casei DN-114 001 reduces the duration of respiratory infections in the elderly in a randomised controlled trial

    • 2009-09-14
    • RCT · n = 1,072
    • British Journal of Nutrition 103(1)
    • • E. Guillemard
      • F. Tondu
      • F. Lacoin
      • J. Schrezenmeir

    • PubMed: 19747410
    • DOI: 10.1017/S0007114509991395

    2 Insights on

    • Reduced Upper Respiratory Tract Infection Days
    • Reduced Duration of Infectious Diseases

    • High evidence
    • Large Human Trial
    • Highly Cited
• September 18

  • Administration of Bacillus coagulans in calves: recovery from faecal samples and evaluation of functional aspects of spores

    • 2009-09-18
    • Veterinary Research Communications 33(8)
    • • B. Ripamonti
      • A. Agazzi
      • A. Baldi
      • C. Balzaretti
      • C. Bersani
      • S. Pirani
      • R. Rebucci
      • G. Savoini
      • S. Stella
      • A. Stenico
      • C. Domeneghini

    • PubMed: 19763863
    • DOI: 10.1007/s11259-009-9318-0

    2 Insights on

    • Increased Fecal Spore Counts
    • Maintained Digestive Function

    • Low evidence
• Undated – 1 supplement study

  • Saccharomyces boulardii inhibits EGF receptor signaling and intestinal tumor growth in Apc(min) mice.

    • 2009-09
    • Clinical Trial
    • Gastroenterology 137(3)
    • • Xinhua Chen
      • J. Fruehauf
      • J. Goldsmith
      • Hua Xu
      • K. Katchar
      • H. Koon
      • Dezheng Zhao
      • E. Kokkotou
      • C. Pothoulakis
      • C. Kelly

    • PubMed: 19482027
    • DOI: 10.1053/j.gastro.2009.05.050

    3 Insights on

    • Reduced Tumor Growth
    • Inhibited EGF Receptor Signaling
    • Inactivated Other Receptor Tyrosine Kinase Activity

    • Low evidence
    • Highly Cited
    • Animal Study